Hair Loss in Hypothyroidism: What to Expect on Levothyroxine

Hypothyroidism slows the hair follicle cycle and pushes more follicles into the resting phase, producing diffuse thinning and outer-eyebrow loss. Most patients see meaningful regrowth within 3 to 6 months of reaching a normal TSH on levothyroxine, with full recovery taking 6 to 12 months.

Why hypothyroidism causes hair loss

The hair follicle is one of the most metabolically active structures in the body, cycling continuously between growth (anagen), regression (catagen), and rest (telogen). Thyroid hormone is a direct regulator of this cycle — it shortens the anagen phase and prolongs telogen when levels fall, which means more follicles sit dormant at any given time and fewer are actively growing hair [C3].

The clinical pattern in hypothyroidism is diffuse, non-scarring thinning — hair sheds more than it regrows, all over the scalp [C3][C4]. Two features are characteristic of thyroid-driven hair loss [C4]:

• Outer-third eyebrow thinning (sometimes called the "Queen Anne's sign") — a recognized clinical clue
• Dry, coarse, brittle hair with a slower growth rate than the patient's baseline

Less commonly, autoimmune thyroid disease can occur alongside alopecia areata (patchy autoimmune hair loss), and Hashimoto's increases the risk of other autoimmune skin conditions [C4][C5].

What the timeline of recovery actually looks like

The most common scenario after starting or adjusting levothyroxine: shedding continues for a few weeks (sometimes worsens), then plateaus, then regrowth begins. The timeline tracks the follicle cycle itself, which takes months [C1][C3]:

• Weeks 1–6: shedding may persist or briefly worsen as follicles synchronize with the new hormone level
• Months 3–6: visible regrowth in most patients with stable TSH in the normal range
• Months 6–12: full restoration of density for most patients

Patients should know this upfront. Hair regrowth is one of the slower-resolving hypothyroid symptoms — slower than fatigue or cold intolerance, which often respond within weeks [C1][C6].

When hair keeps falling despite normal TSH

Several scenarios can prolong or perpetuate shedding even after thyroid hormone normalizes [C3][C6]:

1. Iron deficiency. Low ferritin (below ~30 ng/mL) is a common contributor to telogen effluvium and is over-represented in hypothyroid patients [C3]. Checking ferritin is reasonable when hair loss persists. See our iron-deficiency-thyroid article.
2. Rapid dose changes. Any significant change in thyroid hormone level — including starting treatment, large dose increases or decreases, or pregnancy-related shifts — can trigger telogen effluvium 6 to 12 weeks later [C1][C7]. The shedding is a marker of the gland adjusting; it resolves as the cycle restabilizes.
3. Over-replacement. Suppressed TSH (below 0.1 mIU/L) acts like subclinical hyperthyroidism and can also cause hair loss, paradoxically. The fix is dose reduction, not more "thyroid support" [C1][C7].
4. Concurrent autoimmune skin disease. Hashimoto's patients have a higher prevalence of alopecia areata, vitiligo, and other autoimmune skin conditions [C4][C5]. Persistent patchy hair loss warrants dermatology referral.
5. Other deficiencies. Vitamin D, zinc, biotin, and protein status all affect hair quality. A standard nutritional workup (CBC, ferritin, vitamin D, B12) is reasonable when shedding persists [C3].
6. Postpartum hair loss. Distinct from thyroid-driven loss — postpartum telogen effluvium peaks 3 to 6 months after delivery in most women and resolves on its own. In a Hashimoto's patient it can overlap with postpartum-thyroiditis [C1].

What does NOT help

Several heavily-marketed approaches have no clinical evidence for thyroid-related hair loss [C3][C6]:

• "Thyroid hair regrowth" multivitamin blends — usually contain iodine, biotin, kelp, and ashwagandha. The iodine can destabilize Hashimoto's; biotin interferes with thyroid lab measurement; ashwagandha has documented thyrotoxicosis risk. See our biotin-thyroid-labs and ashwagandha-thyroid articles.
• Minoxidil and finasteride target male/female pattern baldness, not thyroid-driven telogen effluvium. They may help if pattern baldness coexists, but they don't address the underlying thyroid contribution.
• Hair growth supplements (collagen, keratin, biotin megadoses) have very limited trial evidence for any form of hair loss and can complicate thyroid lab interpretation.
• Switching to "natural desiccated thyroid" without a specific indication. The American Thyroid Association recommends levothyroxine as first-line for hypothyroidism [C1].

Practical guidelines

1. Confirm TSH is in target range. Most thyroid-driven hair loss resolves once TSH is stable and within normal range (0.5–2.5 mIU/L often the symptomatic target) [C1].
2. Check ferritin if shedding persists past 6 months. Iron supplementation if below 30–40 ng/mL [C3].
3. Be patient. The hair follicle cycle takes 3 to 6 months to respond to changes; visible regrowth is slower than feeling better [C1][C3].
4. Avoid biotin supplements close to lab testing. Biotin interferes with TSH, free T4, and TPO antibody assays — stop at least 72 hours before any blood draw [C6]. See biotin-thyroid-labs.
5. Tell your endocrinologist about persistent shedding — it can be a sign of under-treatment or over-replacement, both fixable with dose adjustment [C1][C7].
6. See dermatology if hair loss is patchy or scarring. Diffuse thinning is typical of hypothyroidism; patches or visible scarring need a different workup [C4].

Frequently asked questions

Will my hair grow back on levothyroxine? Most patients see meaningful regrowth within 3 to 6 months of reaching stable TSH, with full recovery in 6 to 12 months. Persistent shedding past that warrants checking ferritin, vitamin D, and reconfirming TSH [C1][C3].

Why am I shedding more after starting levothyroxine? A telogen effluvium 6 to 12 weeks after a dose change is common — the follicles are re-synchronizing with the new hormone level. It usually stabilizes and resolves [C1][C7].

Is hair loss a sign of Hashimoto's specifically? Hair loss in autoimmune thyroid disease can come from either hypothyroidism itself or from associated autoimmune skin conditions (alopecia areata, vitiligo) that occur more often in Hashimoto's patients [C4][C5].

Can high doses of levothyroxine cause hair loss? Yes. Over-replacement (TSH suppressed below 0.1 mIU/L) can produce the same telogen-effluvium pattern as under-treatment. The fix is dose reduction [C1][C7].

Does biotin help thyroid hair loss? Biotin has minimal evidence for any non-deficient hair loss, and it interferes with thyroid lab testing — making it harder for your endocrinologist to dose you correctly. Skip it unless your doctor specifically recommends it [C6].

Bottom line

Hair loss is a real and recognized feature of hypothyroidism, driven by thyroid hormone's direct effect on the follicle cycle [C3]. Most patients see meaningful regrowth within 3 to 6 months of reaching a normal TSH on levothyroxine, with full recovery taking 6 to 12 months [C1][C3]. Persistent shedding past 6 months warrants checking ferritin, reconfirming TSH, and ruling out over-replacement [C1][C7]. "Thyroid hair regrowth" supplements lack evidence and can complicate lab testing — the right path is the correct levothyroxine dose plus patience [C6].

Sources

1. [C1] Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670–1751. PubMed: 25266247
2. [C2] Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646–2655. PubMed: 12826640
3. [C3] Owecka B et al. The Hormonal Background of Hair Loss in Non-Scarring Alopecias. 2024. PubMed: 38540126
4. [C4] Cammisa I et al. Skin Sceneries of Thyroid Disorders and Impact of Thyroid on Different Skin Diseases. 2024. PubMed: 39767917
5. [C5] Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391–397. PubMed: 24434360
6. [C6] American Thyroid Association. Hypothyroidism — Patient Information. thyroid.org
7. [C7] Baskaran BS et al. Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review. 2026. PubMed: 41559017

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.